Clinical Trial: Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Meningioma of Brain
Study Type: OBSERVATIONAL
Official Title: Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy: A Retrospective Cohort Study
Brief Summary:
Project Summary: Retrospective Cohort StudyCore ObjectiveThe primary goal is to determine if the volume of Hydroxyethyl Starch (HES) 130/0.4(specifically Voluven® or Volulyte®) administered during the removal of giant meningiomas (tumors > 5 cm) increases the risk of postoperative complications.Research QuestionDoes the volume of intraoperative HES solution influence the rate of re-bleeding (requiring a second surgery within 48 hours) or the development of Acute Kidney Injury (AKI) within 7 days after the…
Read more